Suchergebnisse - "Colman, Roos"

PubPharm (70)

1

A Complement Atlas identifies interleukin 6 dependent alternative pathway dysregulation as a key druggable feature of COVID-19

enthalten in: bioRxiv.org | 2024

von Van Damme, K. | Hoste, L. | Declercq, J. | +17

2

Predictors of augmented renal clearance based on iohexol plasma clearance in critically ill children

enthalten in: Pediatric nephrology (Berlin, Germany) | 2024

von Dhont, E. | Van Der Heggen, T. | Snauwaert, E. | +8

3

RANKL blockade for erosive hand osteoarthritis : a randomized placebo-controlled phase 2a trial

enthalten in: Nature medicine | 2024

von Wittoek, R. | Verbruggen, G. | Vanhaverbeke, T. | +2

4

Validation of a glycomics-based test associated with risk of HCC development in cirrhosis

enthalten in: bioRxiv.org | 2024

von Verhelst, X. | Meuris, L. | Colman, R. | +4

5

Impact of model-informed precision dosing in adults receiving vancomycin via continuous infusion : a randomized, controlled clinical trial

enthalten in: Trials | 2024

von Van Wynsberge, G. | Grootaert, V. | Buyle, F. | +29

6

Impact of model-informed precision dosing in adults receiving vancomycin via continuous infusion: a randomized, controlled clinical trial

enthalten in: Trials | 2024

von Van Wynsberge, G. | Grootaert, V. | Buyle, F. | +6

7

Predictors of augmented renal clearance based on iohexol plasma clearance in critically ill children

enthalten in: Pediatric nephrology | 2023

von Dhont, E. | Van Der Heggen, T. | Snauwaert, E. | +8

8

Microdialysis as a safe and feasible method to study target-site piperacillin-tazobactam disposition in septic piglets and children

enthalten in: International journal of antimicrobial agents | 2023

von Hermans, E. | Devreese, M. | Zeitlinger, M. | +6

9

Incidence of and indications for sperm donor restriction - analysis of patients continuing treatment : a retrospective single-centre study

enthalten in: Reproductive biomedicine online | 2023

von Vanbelleghem, E. | Muyshond, V. | Colman, R. | +4

10

A complement atlas identifies interleukin-6-dependent alternative pathway dysregulation as a key druggable feature of COVID-19

enthalten in: Science translational medicine | 2023

von Van Damme, K. | Hoste, L. | Declercq, J. | +20

1
2
3
4
5
6
7
Nächster »
[7]